Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01924260 | Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer | completed | Phase 1 | 26 | Edward KimOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT02080221 | BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial | completed | Phase 2 | 50 | Brown UniversityOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT02227940 |
| Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer |
| completed |
| Phase 1 |
| 38 |
| Roswell Park Cancer InstituteOTHER |
| 1 |
| Jul 25, 2022 |
| clinicaltrials |
| NCT01497392 | Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | completed | Phase 1 | 26 | Roswell Park Cancer InstituteOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT02347618 | Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer | completed | N/A | 18 | University of RochesterOTHER | 1 | Jul 18, 2022 | clinicaltrials |
| NCT02358356 | Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study(CONTROL NETS) | completed | Phase 2 | 75 | Australasian Gastro-Intestinal Trials GroupNETWORK | 1 | Jul 5, 2022 | clinicaltrials |
| NCT00501176 | Preoperative Stent Study | completed | N/A | 92 | Karolinska InstitutetOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT03086369 | A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 184 | Eli Lilly and CompanyINDUSTRY | 3 | Jun 28, 2022 | clinicaltrials |
| NCT05434520 | Relieving the Bile Ducts Prior to Pancreatoduodenectomy | completed | — | 722 | Rigshospitalet, DenmarkOTHER | 1 | Jun 28, 2022 | clinicaltrials |
| NCT03174574 | Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.(TCOG) | completed | — | 3 | Mayo ClinicOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT02451553 | Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer | completed | Phase 1 | 41 | University of WashingtonOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT04341909 | Trainee Involvement in ERCP Risk Score(TIERS) | completed | — | 1,283 | Clinical Hospital ColentinaOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT01918644 | Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer | completed | Phase 1 | 21 | University of Wisconsin, MadisonOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT02022033 | BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial | completed | Phase 2 | 25 | Brown UniversityOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT03412799 | Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | completed | Phase 1 | 50 | Panbela Therapeutics, Inc.INDUSTRY | 2 | May 25, 2022 | clinicaltrials |
| NCT02704156 | SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer | completed | Phase 2 | 170 | Changhai HospitalOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT03323489 | Celiac Plexus Radio-Surgery for Pain Management | completed | N/A | 125 | Dr. Yaacov LawrenceOTHER_GOV | 4 | May 12, 2022 | clinicaltrials |
| NCT01929915 | Analgesia and Pancreatic Cancer Surgery | completed | N/A | 135 | National Taiwan University HospitalOTHER | 1 | May 11, 2022 | clinicaltrials |
| NCT04416685 | A New Anatomical Classification of Portal Vein Location of Pancreas Tumors | completed | N/A | 43 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 0 | May 11, 2022 | clinicaltrials |
| NCT03731819 | Establishment of Abbreviated Pancreatobiliary MRI Protocol | completed | N/A | 30 | Seoul National University HospitalOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT00710710 | Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer | completed | Phase 2 | 89 | Boehringer IngelheimINDUSTRY | 2 | May 4, 2022 | clinicaltrials |
| NCT02208024 | Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body | completed | N/A | 18 | University of CincinnatiOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT04316078 | A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies | completed | N/A | 126 | Sheba Medical CenterOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05350384 | An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy | completed | — | 1 | University of CataniaOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT01657383 | Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery | completed | — | 74 | Wake Forest University Health SciencesOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT02080260 | A Study of Regorafenib in Advanced Pancreatic Cancer Patients | completed | Phase 2 | 20 | Wake Forest University Health SciencesOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT02702986 | Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC) | completed | Phase 1 | 10 | Universita di VeronaOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT03648632 | Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC)(SBRT-PC-01) | completed | N/A | 32 | Per PfeifferOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT02178709 | A Phase II Study of Neoadjuvant FOLFIRINOX | completed | Phase 2 | 48 | Indiana UniversityOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT04008537 | Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device | completed | N/A | 37 | Washington University School of MedicineOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT00831571 | Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin | completed | — | 112 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 18, 2022 | clinicaltrials |
| NCT01643460 | Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts | completed | N/A | 33 | Indiana UniversityOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT02586844 | Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors(NET-SEQ) | completed | — | 13 | University Health Network, TorontoOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT00826982 | Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer(Sonoma) | completed | — | 90 | Mayo ClinicOTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT03162510 | Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers(SOLAR) | completed | Phase 1 | 18 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT03147768 | Laser Tissue Welding - Distal Pancreatectomy Sealing Study(LTW) | completed | Phase 1 | 11 | Laser Tissue Welding, Inc.INDUSTRY | 1 | Apr 6, 2022 | clinicaltrials |
| NCT02646748 | Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors | completed | Phase 1 | 159 | Incyte CorporationINDUSTRY | 1 | Mar 31, 2022 | clinicaltrials |
| NCT03105921 | Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma | completed | N/A | 20 | Poitiers University HospitalOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT03693378 | A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups | completed | — | 1,349 | Immunovia, Inc.INDUSTRY | 5 | Mar 31, 2022 | clinicaltrials |
| NCT02810418 | Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors | completed | Phase 1 / Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2022 | clinicaltrials |
| NCT02526017 | Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers(FPA008-003) | completed | Phase 1 | 313 | Five Prime Therapeutics, Inc.INDUSTRY | 1 | Mar 9, 2022 | clinicaltrials |
| NCT01360593 | Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma | completed | Phase 2 | 35 | David A. Clump, MD, PhDOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT01675908 | Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression | completed | N/A | 46 | AdventHealthOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT02131493 | S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer | completed | Phase 2 | 80 | Zhejiang UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT03281382 | Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer | completed | Phase 1 | 12 | Henry Ford Health SystemOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT03985072 | Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor | completed | Phase 1 | 67 | Andes BiotechnologiesINDUSTRY | 1 | Feb 24, 2022 | clinicaltrials |
| NCT00617708 | S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 134 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2022 | clinicaltrials |
| NCT00967577 | 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors | completed | Phase 1 | 20 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT02947165 | Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. | completed | Phase 1 | 120 | Novartis PharmaceuticalsINDUSTRY | 9 | Jan 31, 2022 | clinicaltrials |
| NCT03490604 | Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients(ARABICA) | completed | — | 30 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jan 26, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Aug 2, 2022source: clinicaltrials